X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2529) 2529
Publication (131) 131
Book Review (28) 28
Book / eBook (20) 20
Magazine Article (8) 8
Book Chapter (6) 6
Data Set (5) 5
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1625) 1625
male (1520) 1520
hyperlipidemias - chemically induced (1326) 1326
animals (1050) 1050
female (932) 932
hyperlipidemia (751) 751
hyperlipidemias - drug therapy (635) 635
index medicus (629) 629
rats (624) 624
adult (611) 611
middle aged (597) 597
triglycerides - blood (543) 543
cholesterol - blood (433) 433
hyperlipidemias - blood (351) 351
lipids - blood (350) 350
risk factors (343) 343
pharmacology & pharmacy (322) 322
cholesterol (303) 303
hiv infections - drug therapy (291) 291
aged (272) 272
mice (259) 259
hyperlipidemias - complications (248) 248
hyperlipidemias - metabolism (244) 244
liver - metabolism (222) 222
lipids (200) 200
hypolipidemic agents - therapeutic use (194) 194
atherosclerosis (186) 186
disease models, animal (183) 183
liver - drug effects (173) 173
metabolism (168) 168
lipid metabolism (163) 163
rats, wistar (162) 162
hiv protease inhibitors - adverse effects (160) 160
insulin-resistance (159) 159
lipoproteins - blood (158) 158
time factors (153) 153
immunology (151) 151
insulin resistance (150) 150
infectious diseases (146) 146
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (140) 140
hypolipidemic agents - pharmacology (140) 140
triglycerides (139) 139
rats, sprague-dawley (137) 137
protease inhibitors (134) 134
medicine, general & internal (132) 132
rabbits (131) 131
dose-response relationship, drug (129) 129
risk (129) 129
antiretroviral therapy, highly active - adverse effects (127) 127
oxidative stress (127) 127
therapy (127) 127
biochemistry & molecular biology (126) 126
drug therapy, combination (125) 125
hyperlipidemias - prevention & control (124) 124
adolescent (123) 123
hypercholesterolemia (122) 122
research (120) 120
cholesterol, ldl - blood (119) 119
liver (118) 118
antipsychotic agents - adverse effects (115) 115
diabetes (114) 114
cardiac & cardiovascular systems (113) 113
anti-hiv agents - adverse effects (111) 111
lipoproteins (111) 111
diet (110) 110
dyslipidemia (110) 110
hypolipidemic agents - adverse effects (110) 110
disease (109) 109
lipodystrophy (109) 109
obesity (109) 109
treatment outcome (109) 109
statins (107) 107
hyperlipidemias - etiology (106) 106
endocrinology & metabolism (105) 105
health aspects (103) 103
cholesterol, hdl - blood (101) 101
retrospective studies (101) 101
hiv (100) 100
hyperlipidemias - pathology (100) 100
rhabdomyolysis - chemically induced (98) 98
blood glucose - metabolism (97) 97
hyperlipidemias - epidemiology (97) 97
hypercholesterolemia - chemically induced (95) 95
drug interactions (94) 94
hypertriglyceridemia - chemically induced (92) 92
drug therapy (91) 91
hiv infections - complications (91) 91
diabetes mellitus - chemically induced (90) 90
fatty acids, nonesterified - blood (90) 90
hyperlipidemias - genetics (90) 90
hypertriglyceridemia (90) 90
peripheral vascular disease (90) 90
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (89) 89
plant extracts - pharmacology (88) 88
psychiatry (88) 88
glucose (87) 87
physiological aspects (87) 87
analysis (86) 86
hypertension (86) 86
care and treatment (85) 85
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2229) 2229
French (88) 88
German (78) 78
Spanish (35) 35
Russian (34) 34
Japanese (23) 23
Polish (22) 22
Italian (15) 15
Chinese (10) 10
Hebrew (5) 5
Dutch (4) 4
Romanian (4) 4
Swedish (4) 4
Norwegian (3) 3
Bulgarian (2) 2
Finnish (2) 2
Ukrainian (2) 2
Croatian (1) 1
Danish (1) 1
Hungarian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CA: A Cancer Journal for Clinicians, ISSN 0007-9235, 07/2013, Volume 63, Issue 4, pp. 249 - 279
Answer questions and earn CME/CNE Advances in genomics and molecular biology have identified aberrant proteins in cancer cells that are attractive targets for... 
toxicity | kinase inhibitors | therapeutic index | targeted agents | mechanism‐based toxicity | immunotherapeutic agents | off‐target toxicity | mechanism-based toxicity | off-target toxicity | MEK INHIBITOR TRAMETINIB | PULMONARY ARTERIAL-HYPERTENSION | I DOSE-ESCALATION | CHRONIC MYELOID-LEUKEMIA | GROWTH-FACTOR RECEPTOR | ONCOLOGY | PLACEBO-CONTROLLED TRIAL | III CLINICAL-TRIAL | SQUAMOUS-CELL CARCINOMAS | TIVANTINIB ARQ 197 | SIGNAL-REGULATED KINASE | Mood Disorders - chemically induced | Drug Eruptions - etiology | Peripheral Nervous System Diseases - chemically induced | Bone Marrow Diseases - chemically induced | Cachexia - chemically induced | Endocrine System Diseases - chemically induced | Pleural Effusion - chemically induced | Humans | Drug Eruptions - therapy | Immune System Diseases - chemically induced | Lung Diseases, Interstitial - chemically induced | Thrombocytopenia - chemically induced | Diarrhea - chemically induced | Neoplasms - drug therapy | Antineoplastic Agents - adverse effects | Exanthema - chemically induced | Hyperbilirubinemia - chemically induced | Venous Thromboembolism - chemically induced | Vision Disorders - chemically induced | Hemorrhage - chemically induced | Heart Diseases - chemically induced | Hyperlipidemias - chemically induced | Magnesium - blood | Antimitotic agents | Drugs | Prevention | Complications and side effects | Drug targeting | Antineoplastic agents | Health aspects | Risk factors | Proteins | Side effects | Genomics | Cytotoxicity | Molecular biology | Cancer therapies | Cells | Index Medicus | Abridged Index Medicus
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 67, Issue 20, pp. 2395 - 2410
Abstract Hydroxy-methyl-glutaryl-coenzyme A (HMG-CoA) reductase inhibitors or statins are well tolerated, but associated with various statin-associated... 
Cardiovascular | Internal Medicine | rhabdomyolysis | skeletal muscle | interstitial lung disease | myopathy | C-REACTIVE PROTEIN | RANDOMIZED CONTROLLED-TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | FORCE 2014 UPDATE | PRIMARY-PREVENTION TRIAL | INDUCED MUSCLE TOXICITY | INTERSTITIAL LUNG-DISEASE | CENTRAL-NERVOUS-SYSTEM | OF-THE-LITERATURE | CORONARY-HEART-DISEASE | TYPE-2 DIABETES-MELLITUS | Liver Function Tests | Sleep Wake Disorders - chemically induced | Hydroxymethylglutaryl-CoA Reductase Inhibitors - immunology | Myalgia - chemically induced | Humans | Hyperlipidemias - drug therapy | Risk Factors | Lung Diseases, Interstitial - chemically induced | Tendon Injuries - chemically induced | Necrosis - chemically induced | Brain - drug effects | Rupture - chemically induced | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Stroke - chemically induced | Cognition Disorders - etiology | Depression - chemically induced | Rhabdomyolysis - chemically induced | Antibodies - blood | Diabetes Mellitus - chemically induced | Acute Kidney Injury - chemically induced | Muscular Diseases - chemically induced | Testosterone - blood | Autoimmune Diseases - chemically induced | Hyperlipidemias - complications | Viral antibodies | Complications and side effects | Enzymes | Thiols | Antibodies | Diabetes | Cardiology | Statins | Cardiovascular agents | Creatine kinase | Muscles | Creatine | Respiratory tract diseases | Studies | Musculoskeletal system | Genotype & phenotype | Mortality | Clinical trials | Lipids | Clinical medicine
Journal Article
American Journal of Psychiatry, ISSN 0002-953X, 08/2004, Volume 161, Issue 8, pp. 1334 - 1349
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 05/2014, Volume 15, Issue 5, pp. 9160 - 9172
Journal Article
Critical Care Medicine, ISSN 0090-3493, 06/2010, Volume 38 Suppl, Identification and Prevention of Common Adverse Drug Events in the Intensive Care Unit, Issue 6, pp. S231 - S243
As critically ill patients frequently receive analgesics, sedatives, and antipsychotics to optimize patient comfort and facilitate mechanical ventilation,... 
Coma | Delirium | Dverse drug events | Benzodiazepine | Critical care | Fentanyl | Opioid | Pharmacology | Haloperidol | Drug safety | Intensive care unit | Prevention | Analgesic | Dexmedetomidine | Antipsychotic | Lorazepam | Midazolam | Propofol | Sedative | dexmedetomidine | analgesic | propofol | critical care | QTC INTERVAL | MECHANICALLY VENTILATED PATIENTS | haloperidol | PROPOFOL INFUSION SYNDROME | midazolam | fentanyl | pharmacology | antipsychotic | intensive care unit | LONG-TERM SEDATION | sedative | delirium | prevention | benzodiazepine | CRITICAL CARE MEDICINE | drug safety | opioid | lorazepam | coma | ATYPICAL ANTIPSYCHOTICS | HIGH-DOSE DEXMEDETOMIDINE | adverse drug events | HUMAN NEUTROPHIL FUNCTIONS | TORSADE-DE-POINTES | PROPYLENE-GLYCOL TOXICITY | CRITICALLY-ILL PATIENTS | Critical Care - methods | Drug-Related Side Effects and Adverse Reactions - prevention & control | Hypnotics and Sedatives - adverse effects | Drug-Related Side Effects and Adverse Reactions - chemically induced | Endocrine System Diseases - chemically induced | United States | Antipsychotic Agents - adverse effects | Humans | Excipients - adverse effects | Fatty Liver - chemically induced | Infection - etiology | Muscular Diseases - chemically induced | Propofol - administration & dosage | Analgesics - adverse effects | Intensive Care Units | Infection - immunology | Acidosis - chemically induced | Substance Withdrawal Syndrome | Syndrome | Bradycardia - chemically induced | Immune System - drug effects | Nervous System Diseases - chemically induced | Cardiovascular Diseases - chemically induced | Infusions, Intravenous | Hyperlipidemias - chemically induced | Drug-Related Side Effects and Adverse Reactions - physiopathology | Gastrointestinal Diseases - chemically induced | Propofol - adverse effects | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Psychiatry, ISSN 0160-6689, 2004, Volume 65, Issue 7, pp. 4 - 18
Journal Article